In addition to oncogenic EGFR and distinct RTKs activated through gene-rearrangements, increased expression of the non-mutated RTK, FGFR1, is observed in lung cancers of all histologies [82–86], mesotheliomas [87] and HNSCC [88–91]. The gene discussed is FGFR1; the disease is lung cancer.